Stockreport

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

Dyadic International, Inc.  (DYAI) 
NASDAQ:AMEX Investor Relations: dyadic.com
PDF Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated su [Read more]